Elsevier Publishes Five New Immunology Books

New edition textbook Primer to the Immune Response Featured at the International Congress on Autoimmunity

Waltham, MA, March 26, 2014

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of five new immunology books, including the new edition of Primer to The Immune Response by Tak Mak, Mary Saunders and Bradley Jett. All five new books will be on display at Elsevier booth # 4C at this week’s 9th International Congress on Autoimmunity in Nice, France. The host for the congress is Yehuda Shoenfeld, who is also an editor of the new book, Autoantibodies.

Primer to The Immune Response is a unique textbook with a completely updated, concise but comprehensive introduction to immunology. The text is written in an engaging conversational style that is to the point and very readable, and includes more than 200 color illustrations along with a comprehensive glossary and list of abbreviations. Published by Elsevier under the Academic Cell imprint, the book contains research passages on current experimental work published in Cell Press articles. These articles also form the basis of case studies that are found in the associated online study guide and are designed to reinforce clinical connections.

Lead author Dr. Tak Mak is the Director of the Campbell Family Institute for Breast Cancer Research in the Princess Margaret Hospital, Toronto and a University Professor in the Departments of Medical Biophysics and Immunology, University of Toronto. He gained worldwide prominence in 1984 as the leader of the team that first cloned the genes of the human T cell antigen receptor. Dr. Mak’s current research remains centered on mechanisms of immune recognition/regulation, malignant cell survival/death, inflammation in autoimmunity and cancer, and metabolic adaptation in tumor cells. He has published over 700 papers and holds many patents.

The five new immunology books published are:

The books are available on the Elsevier Store and on ScienceDirect, Elsevier’s full-text scientific database offering journal articles and book chapters from more than nearly 2,200 peer-reviewed journals, almost 900 serials and 25,000 book titles.

---

Notes for editors
Review copies of the books are available to credentialed journalists upon request. Contact Michelle McMahon at m.mcmahon.1@elsevier.com or +1 781 663 2268.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Michelle McMahon
Publicity Manager, Science & Technology Books
Elsevier
+1 781 663 2268
m.mcmahon.1@elsevier.com